Leadercare
CLOSE X

Tata India Pharma & Healthcare Fund-Reg(G)

As on Apr-19-2024 change fund
24.54  up-0.21 (-0.85%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)8.9314.7317.1815.8825.06
Net Assets(Rs Crores) (as on 31-Mar-2024) 152.64 435.03 553.33 493.44 878.70
Scheme Returns(%)(Absolute)-2.1967.2416.04-7.3157.46
B'mark Returns(%)(Absolute)NANANANANA
Category Rank11/7549/7541/7567/7619/90
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2023-202415.1911.1111.3810.75
2022-2023-10.368.14-0.52-4.19
2021-202216.843.710.97-4.64
2020-202125.0721.7811.24-2.68
2019-2020-4.661.784.39-2.98
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...14.56 
Lupin Ltd.9.39 
Aurobindo Pharma Ltd.8.87 
Cipla Ltd.7.07 
Zydus Lifesciences Ltd.5.40 
Dr. Reddy's Laboratories Ltd.5.08 
Apollo Hospitals Enterprise Ltd.4.26 
Divi's Laboratories Ltd.4.12 
Fortis Healthcare Ltd.4.09 
Alkem Laboratories Ltd.3.83 

Category

Sector Funds

Launch Date

28-Dec-15

ISIN Code

INF277K016A9

Scheme Benchmark

NIFTY PHARMA - TRI

AUM ( in Cr.)

878.70

portfolio price to book value

5.87

investing style?

Large Growth

fund manager?

Meeta Shetty

inception date (regular plan)

28-Dec-15

expense ratio (regular plan) %

2.24

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs78.22
Hospital & Healthcare Services13.21
Business Support3.27
Fertilizers0.73
Chemicals0.43

Growth Chart of the Scheme

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015878.7049.0815.8721.71NA11.40
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19992,626.3451.4117.9922.8515.5016.06
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20183,772.3256.3117.6524.05NA21.11
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20182,352.3248.5616.3725.36NA24.15
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20047,125.2847.8415.6022.1916.8620.65
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,235.1544.9414.6723.08NA21.11
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019699.5551.7814.04NANA21.78
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005947.2647.0814.0020.5413.6317.94
LIC MF Healthcare Fund-Reg(G)Large-Growth 28-Feb-201961.6942.2110.7518.40NA18.15
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021160.3943.70NANANA12.49
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-2023800.65NANANANA22.78
WOC Pharma and Healthcare Fund-Reg(G)Large-Growth 06-Feb-2024108.61NANANANA-1.13
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023284.18NANANANA10.38
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023264.51NANANANA34.66
ENTRY LOAD / EXIT LOAD
Max Entry Load [%]
0.00
Entry Remark
Max Exit Load [%]
0.25
Exit Remark
0.25% on or before 30D
52 Week Highs & Lows
52 Week High
25.53
52 Week Low
16.29
portfolio characteristics
As on 31-Mar-2024
Average Maturity
N.A
Modified Duration
N.A
Yield to Maturity
N.A.
Portfolio Turnover Ratio
31.34 Times
ratios
Statistical Ratios
Standard Deviation [%]
13.7327
Semi Standard Deviation [%]
0.3618
Beta [%]
0.4208
Sharp Ratio [%]
1.1430
R-Square [%]
0.3671
Expense Ratio [%]
2.2400
AVG Ratio [%]
0.0818
Other Ratios
Jenson Ratio [%]
0.1326
Treynor Ratio [%]
0.3860
Turnover Ratio [%]
31.3400
FAMA Ratio [%]
0.1183
SORTINO Ratio [%]
0.1959
HEAD OFFICE Leader Care A-507/8 Navratna Corporate Park, Ashok Vatika Bopal-Ambli Road, Ahmedabad-380058
DISCLAIMER

Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objective of the Scheme will be achieved. Past performance of the Sponsor/AMC/Fund or that of any scheme of the Fund does not indicate the future performance of the Schemes of the Fund. Please read the Key Information Memorandum and the Offer Document carefully before investing.

  • INSURANCE DISCLAIMER - Insurance is a subject matter of solicitation
  • ARN Number - 11439
  • IRDAI Licence Number - AGQ0127782

Copyright © 2019Leader CareAll rights reserved

Designed, Developed & Content Powered by Accord Fintech Pvt. Ltd.